Share markets in India are presently trading on a negative note.
The BSE Sensex is trading down by 383 points, down 0.7%, at 52,170 levels.
Meanwhile, the NSE Nifty is trading down by 128 points.
UltraTech Cement and HUL are among the top gainers today. Hindalco and HCL Technologies are among the top losers today.
The BSE Mid Cap index is trading down by 1.4%.
The BSE Small Cap index is trading up by 1.6%.
On the sectoral front, barring the FCMG sector, all sectors are trading in red with stocks from the real estate sector, witnessing most of the selling pressure.
US stock futures are trading higher today, indicating a positive opening for Wall Street.
Nasdaq Futures are trading up by 82 points (up 0.6%) while Dow Futures are trading up by 121 points (up 0.4%).
The rupee is trading at 74.84 against the US$.
Gold prices are trading down by 0.2% at Rs 48,194 per 10 grams.
Gold prices edged higher today in Indian markets, pushing prices to near a one-month high. On MCX, gold futures were up 0.4% to Rs 48,278 per 10 grams. In the previous session, gold had edged up 0.1%.
In global markets, gold rates edged higher today as a rebound in Covid-19 cases across the world boosted the safe-haven appeal of the precious metal. Spot gold rose 0.3% to US$ 1,818.3 an ounce.
Gold was also supported by dip in US bond yields. Lower bond yields reduce the opportunity cost of holding non-interest bearing gold.
Note that international markets, gold has rebounded this month to trade above US$ 1,800 an ounce after a plunge in June amid fears over the pace of monetary tightening by the US Fed. In India, gold had hit a record high of Rs 56,200 in August last year.
Speaking of the precious yellow metal, how lucrative has gold been as a long-term investment in India?
The chart below shows the annual returns on gold over the last 15 years...
As you can see, barring just two years - 2013 and 2015, gold has delivered positive returns in 13 of the last 15 years.
Even with the recent volatility in prices, gold and silver remain among the best performing commodities this year to combat the fallout from the coronavirus pandemic.
To know more about gold, check out our article on how to invest in gold here: How to Invest in Gold?
Moving on to stock-specific news...
Among the buzzing stocks today is ACC.
Shares of ACC jumped as much as 7% during early trade today after the company reported an over two-fold jump in consolidated net profit for the June 2021 quarter.The cement maker posted a net profit of Rs 5.7 bn, compared to a profit of Rs 2.7 bn in the same period last year, ACC said in a BSE filing.
The company follows a January-December financial year.The company's revenue from operations came in at Rs 38.8 bn for the quarter, up 49.3% from Rs 26 bn in the June 2020 quarter.
Revenue from cement rose 44% to Rs 36.7 bn, as against Rs 25.5 bn in the corresponding quarter of the previous year.
On the other hand, revenue from ready-mix concrete increased four-fold to Rs 2.6 bn against Rs 622.3 m. ACC, a subsidiary of Swiss building material major Holcim group (earlier LafargeHolcim), witnessed an improvement in performance on account of a lower base and an increase in sales and cost efficiency.
We will keep you posted on more updates from this space. Stay tuned.
At the time of writing, ACC shares were trading up by 2.3% on the BSE.
Speaking of the stock markets, India's #1 trader, Vijay Bhambwani talks about OPEC and his next crude oil trade, in his latest video for Fast Profits Daily.
Tune in here to find out more:
Moving on to news from the IPO space...
The Rs 16 bn initial public offering of Glenmark Life Sciences (GLS), a unit of Glenmark Pharmaceuticals, is likely to be launched later this month.
The company filed an updated draft red herring prospectus (DRHP) last week.The initial public offering (IPO) comprises a fresh issue of Rs 11.6 bn and sale of 7.3 m shares by listed promoter Glenmark Pharmaceuticals.
Glenmark Life would be the fifth IPO to be launched in July after GR Infraprojects, Clean Science and Technology, Zomato and Tatva Chintan Pharma.
The last IPO from the pharmaceutical sector was from Gland Pharma, which raised Rs 64.8 bn in November 2020. Since its listing, Gland Pharma shares have returned 164%.
Glenmark Life Sciences is a developer and manufacturer of high value, non-commoditised APIs (active pharmaceutical ingredients).
Its products are used to treat illnesses linked to cardiovascular, central nervous system therapy, diabetes and anti-infectives.
How this pans out remains to be seen. Meanwhile, stay tuned for more updates from this space.
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Sensex Plunges Amid Global Sell-Off, Dow Futures Up by 121 Points". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!